Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Developing Human Immunotherapies

Adria Botella

Blaine Crissman is with South Dakota Equity Partners and Eddie Sullivan is with SAB Biotherapeutics. SAB Biotherapeutics is a clinical-stage biopharmaceutical company developing human immunotherapies. SDEP is investing $1 million dollars in SAB. This is the first investment made by the new private equity fund focusing on South Dakota growth-stage companies.

Credit Adria Botella
Eddie Sullivan

Cara Hetland is the Director of Radio and Journalism Content for South Dakota Public Broadcasting.